Nisa Investment Advisors’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$925K Buy
9,306
+675
+8% +$88K ﹤0.01% 805
2025
Q4
$1.05M Sell
8,631
-22
-0.3% -$2.76K ﹤0.01% 810
2025
Q3
$971K Sell
8,653
-8,857
-51% -$1.04M ﹤0.01% 849
2025
Q2
$2.35M Buy
17,510
+1,686
+11% +$185K 0.01% 594
2025
Q1
$1.06M Buy
15,824
+256
+2% +$17.6K 0.01% 809
2024
Q4
$971K Sell
15,568
-23
-0.1% -$2.14K ﹤0.01% 874
2024
Q3
$2.45M Sell
15,591
-4
-0% -$616 0.01% 618
2024
Q2
$2.35M Buy
15,595
+25
+0.2% +$3K 0.01% 644
2024
Q1
$1.15M Buy
15,570
+28
+0.2% +$2.31K 0.01% 841
2023
Q4
$1.23M Hold
15,542
0.01% 795
2023
Q3
$851K Hold
15,542
0.01% 910
2023
Q2
$1.31M Hold
15,542
0.01% 809
2023
Q1
$1.18M Sell
15,542
-30
-0.2% -$2.08K 0.01% 809
2022
Q4
$961K Hold
15,572
0.01% 923
2022
Q3
$657K Buy
15,572
+22
+0.1% +$957 0.01% 938
2022
Q2
$489K Buy
15,550
+450
+3% +$12K ﹤0.01% 1070
2022
Q1
$407K Buy
+15,100
New +$271K ﹤0.01% 1143

Other funds holding TMDX

Nisa Investment Advisors's TMDX Position: Q1 2026 in Review

Nisa Investment Advisors increased its Transmedics (TMDX) stake by 7.8% in Q1 2026, buying an estimated $88K and bringing the position to 9,306 shares worth $925K. The position accounts for ﹤0.01% of the portfolio, ranked #805.

Nisa Investment Advisors first reported a position in TMDX in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.45M in Q3 2024. 415 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Nisa Investment Advisors held 9,306 shares of Transmedics worth $925K as of Q1 2026.
  • Nisa Investment Advisors bought 675 Transmedics shares in Q1 2026, an estimated $88K.
  • Transmedics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #805 holding.
  • Nisa Investment Advisors first reported a position in Transmedics in Q1 2022 and has held it in 17 quarters since.
  • Nisa Investment Advisors's Transmedics position peaked at $2.45M in Q3 2024.
  • 415 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.